Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial.

Key Findings

• ●Significant NPS and nasal blockage improvement
• ●Near-complete tissue eosinophil depletion via ADCC
• ●FDA-approved 2024 for CRSwNP
• ●Benefit in high-eosinophil patients

Referenced in (1 disease)

1. passsource metadataJun 1, 2026, 04:57 PMby pubmed-api

   Identifier re-resolved by title (deeper second pass): prior entry (doi-10-1016-s0140-6736-23-02873-0) had a fabricated/wrong identifier; repointed to this record via PubMed/Crossref.

   tools: pubmed.esummary, crossref.works